Johnson & Johnson (JNJ) stock is in focus as the FDA greenlights the company's Rybrevant injectable developed with Halozyme ...

In a study published in The Journal of Clinical Investigation, University of Michigan researchers found a new protein target ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to GSK’227, now known as risvutatug rezetecan ...

When treated with KRAS inhibitors alone, cancer cells can escape destruction by using the salvage pathway to gather ...

The Food and Drug Administration (FDA) has granted traditional approval to Imdelltra ® (tarlatamab-dlle) for the treatment of adults with extensive stage small cell lung cancer (ES-SCLC) with disease ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that Johnson & Johnson has received approval from the U.S. Food and Drug Administration (FDA) for RYBREVANT FASPRO™ (amivantamab ...

Wendy Brooks, a patient with extensive-stage small cell lung cancer, and her husband and care partner, Larry Brooks, sat down ...

A small cell lung cancer (SCLC) misdiagnosis is possible. This can occur because of challenges during the diagnostic tests and because SCLC may share symptoms and causes similar to other conditions.

编者按：肺癌是一类发病率和致死率极高的恶性肿瘤，根据世界卫生组织国际癌症研究机构团队2024年的报告，每年约有180万人死于肺癌，几乎相当于每3分钟就有10人因此去世。进入21世纪，随着科学界陆续发现了肺癌患者携带的一系列特定突变，对应的靶向疗法应运 ...

Ask a clinical question and tap into Healio AI's knowledge base. Lung cancer is generally the top cause of cancer-related death globally and in the United States (US). In the US in 2023, lung cancer ...